0.00Open2.18Pre Close0 Volume523 Open Interest20.00Strike Price0.00Turnover39.29%IV2.00%PremiumJan 17, 2025Expiry Date1.75Intrinsic Value100Multiplier21DDays to Expiry0.44Extrinsic Value100Contract SizeAmericanOptions Type0.8443Delta0.1160Gamma10.61Leverage Ratio-0.0137Theta0.0094Rho8.96Eff Leverage0.0125Vega
Life Time Stock Discussion
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%, ...
No comment yet